Project Details
Project Description
NMA HREC Reference Number: HREC/18/MonH/196
Monash Health Ref: 18-0000-235A
Monash Health Ref: 18-0000-235A
| Status | Finished |
|---|---|
| Effective start/end date | 12/12/18 → 11/12/23 |
A randomized, open label, multicenter Phase 2/3 study to evaluate the efficacy and safety of rogaratinib (BAY 1163877) compared to chemotherapy in patients with FGFR-positive locally advanced or metastatic urothelial carcinoma who have received prior platinum containing chemotherapy
- Pook, David (Primary Chief Investigator (PCI))
Project: Research